These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25375398)

  • 1. The Pseudomonas aeruginosa type III translocon is required for biofilm formation at the epithelial barrier.
    Tran CS; Rangel SM; Almblad H; Kierbel A; Givskov M; Tolker-Nielsen T; Hauser AR; Engel JN
    PLoS Pathog; 2014 Nov; 10(11):e1004479. PubMed ID: 25375398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilms: The T3SS translocon in biofilm formation.
    Du Toit A
    Nat Rev Microbiol; 2015 Jan; 13(1):2-3. PubMed ID: 25417658
    [No Abstract]   [Full Text] [Related]  

  • 3. Motility-Independent Formation of Antibiotic-Tolerant Pseudomonas aeruginosa Aggregates.
    Demirdjian S; Sanchez H; Hopkins D; Berwin B
    Appl Environ Microbiol; 2019 Jul; 85(14):. PubMed ID: 31076438
    [No Abstract]   [Full Text] [Related]  

  • 4. Detrimental Effect of Type I IFNs During Acute Lung Infection With
    Pylaeva E; Bordbari S; Spyra I; Decker AS; Häussler S; Vybornov V; Lang S; Jablonska J
    Front Immunol; 2019; 10():2190. PubMed ID: 31572395
    [No Abstract]   [Full Text] [Related]  

  • 5. An in vitro model of Pseudomonas aeruginosa biofilms on viable airway epithelial cell monolayers.
    Woodworth BA; Tamashiro E; Bhargave G; Cohen NA; Palmer JN
    Am J Rhinol; 2008; 22(3):235-8. PubMed ID: 18588754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa.
    Li Y; Petrova OE; Su S; Lau GW; Panmanee W; Na R; Hassett DJ; Davies DG; Sauer K
    PLoS Pathog; 2014 Jun; 10(6):e1004168. PubMed ID: 24901523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental pneumonia with Pseudomonas aeruginosa in immunosuppressed guinea pigs as a model for biofilm-associated infection].
    Ishida Y
    Kansenshogaku Zasshi; 1995 May; 69(5):572-81. PubMed ID: 7602191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psl Produced by Mucoid
    Jones CJ; Wozniak DJ
    mBio; 2017 Jun; 8(3):. PubMed ID: 28634241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
    Li Q; Zhou X; Nie X; Yang J
    Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.
    Pestrak MJ; Chaney SB; Eggleston HC; Dellos-Nolan S; Dixit S; Mathew-Steiner SS; Roy S; Parsek MR; Sen CK; Wozniak DJ
    PLoS Pathog; 2018 Feb; 14(2):e1006842. PubMed ID: 29394295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A confocal microscopy image analysis method to measure adhesion and internalization of Pseudomonas aeruginosa multicellular structures into epithelial cells.
    Lepanto P; Lecumberry F; Rossello J; Kierbel A
    Mol Cell Probes; 2014 Feb; 28(1):1-5. PubMed ID: 24416791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal Biofilms: From Planktonic to Microcolony Formation in an Experimental Keratitis Infection with Pseudomonas Aeruginosa.
    Saraswathi P; Beuerman RW
    Ocul Surf; 2015 Oct; 13(4):331-45. PubMed ID: 26220579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.
    Gellatly SL; Hancock RE
    Pathog Dis; 2013 Apr; 67(3):159-73. PubMed ID: 23620179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway epithelial cell tolerance to Pseudomonas aeruginosa.
    Wu Q; Lu Z; Verghese MW; Randell SH
    Respir Res; 2005 Apr; 6(1):26. PubMed ID: 15804356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa Aggregate Formation in an Alginate Bead Model System Exhibits
    Sønderholm M; Kragh KN; Koren K; Jakobsen TH; Darch SE; Alhede M; Jensen PØ; Whiteley M; Kühl M; Bjarnsholt T
    Appl Environ Microbiol; 2017 May; 83(9):. PubMed ID: 28258141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa Leucine Aminopeptidase Influences Early Biofilm Composition and Structure via Vesicle-Associated Antibiofilm Activity.
    Esoda CN; Kuehn MJ
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744920
    [No Abstract]   [Full Text] [Related]  

  • 17. Biofilms and type III secretion are not mutually exclusive in Pseudomonas aeruginosa.
    Mikkelsen H; Bond NJ; Skindersoe ME; Givskov M; Lilley KS; Welch M
    Microbiology (Reading); 2009 Mar; 155(Pt 3):687-698. PubMed ID: 19246740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.
    Lashua LP; Melvin JA; Deslouches B; Pilewski JM; Montelaro RC; Bomberger JM
    J Antimicrob Chemother; 2016 Aug; 71(8):2200-7. PubMed ID: 27231279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of ExoS on
    Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
    mBio; 2018 May; 9(3):. PubMed ID: 29717012
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucosal biofilm formation on middle-ear mucosa in a nonhuman primate model of chronic suppurative otitis media.
    Dohar JE; Hebda PA; Veeh R; Awad M; Costerton JW; Hayes J; Ehrlich GD
    Laryngoscope; 2005 Aug; 115(8):1469-72. PubMed ID: 16094127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.